Concepts and challenges of biosimilars to mitigate the oncology drug expenses

Concepts and challenges of biosimilars to mitigate the oncology drug expenses

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Bibliografische gegevens
Hoofdauteur:	Tania, Umme
Andere auteurs:	Haque , Md. Aminul
Formaat:	Thesis
Taal:	en_US
Gepubliceerd in:	Brac University 2021
Onderwerpen:	Biosimilars Interchangeability Cancer therapy Monoclonal antibodies Biologic medicines Comparability exercise
Online toegang:	http://hdl.handle.net/10361/15111

Gelijkaardige items

Biosimilar in lymphoma treatment
door: Tanisha, Mehrin Haque
Gepubliceerd in: (2021)

Biosimilar insulins: a potential option in the treatment of Diabetes
door: Tabassum, Turana
Gepubliceerd in: (2022)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
door: Tania, Umme
Gepubliceerd in: (2023)

Advancement of Antibody-Drug conjugates in cancer treatment: A review
door: Sagar, Baejid Hossain
Gepubliceerd in: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
door: Fred, Namanda Rogers
Gepubliceerd in: (2021)

A review on targeted therapies for lung cancer
door: Ashraf, Anushey
Gepubliceerd in: (2023)

Osteoarthritis: a multi-disciplinary factual review
door: Subah, Nowshin
Gepubliceerd in: (2021)

Biosimilars: A revolution for biologics in the pharmaceutical industry
door: Moreino, Shannon Sherwin
Gepubliceerd in: (2018)

Biologics and Biosimilars as Treatment Options for Psoriasis
door: Moya, Amena Khatun
Gepubliceerd in: (2023)

Targeted therapeutic options in the treatment of Breast Cancer
door: Alam, Kazi Tasnuva
Gepubliceerd in: (2022)

In vivo propagation of monoclonal antibodies in ascites fluid produced in BALB/c mice: characterization and diagnostic application for the identification of Vibrio cholerae O1
door: Chowdhury, Mashiat Nawar
Gepubliceerd in: (2018)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
door: Choki, Kinley
Gepubliceerd in: (2024)

Post Covid-19 health indications of Covid-19 patients
door: Khan, Tanzim
Gepubliceerd in: (2022)

Recent advancement of biologics in Asthma
door: Evan, Al- Shahriar
Gepubliceerd in: (2022)

PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
door: Lubaba, Anikah
Gepubliceerd in: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
door: Ratu, Tabassum
Gepubliceerd in: (2024)

A comprehensive review on drug repurposing in cancer treatment
door: Sarkar, Onusree
Gepubliceerd in: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
door: Chakraborty, Anuradha
Gepubliceerd in: (2024)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
door: Hoque, Syeda Mehren
Gepubliceerd in: (2024)

Breast cancer therapy through Liposomal drug delivery system
door: Ome, Nusrat Jahan
Gepubliceerd in: (2024)

An improved chromosome sorting algorithm by permutation group-based inverted block-interchanges
door: Tabassum, Afrida, et al.
Gepubliceerd in: (2018)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
door: Akter, Anika
Gepubliceerd in: (2022)

Risk of cancer associated with antihypertensive drugs
door: Iqbal, Adnan
Gepubliceerd in: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
door: Jahan, Nusrat
Gepubliceerd in: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
door: Rattry, Faria Rahman
Gepubliceerd in: (2024)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
door: Rahman, Sanjida
Gepubliceerd in: (2024)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
door: Hasan, Sakib
Gepubliceerd in: (2024)

Immunotherapy in the Management of Lung Cancer
door: Tasnim, Humayra
Gepubliceerd in: (2022)

Biosimilars
Gepubliceerd in: (2013)

Biosimilars

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
door: Dowla, Rumana, et al.
Gepubliceerd in: (2022)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
door: Razna, Amrin Islam
Gepubliceerd in: (2019)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
door: Kamal, Tasnova
Gepubliceerd in: (2019)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
door: Parvez, Safi
Gepubliceerd in: (2023)

Sugar based biopolymers in nanomedicine: a review
door: Juthy, Afrin Rahman
Gepubliceerd in: (2024)

A review on combinatorial therapies in Melanoma
door: Ahmmed, Md. Kawsar
Gepubliceerd in: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
door: Hasan, Amit
Gepubliceerd in: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
door: Nahar, Kamrun
Gepubliceerd in: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
door: Nashrah, Zannatul
Gepubliceerd in: (2023)

Food, nutrition, physical activity and the prevention of cancer : a global perspective : a project of World Cancer Research Fund International.
Gepubliceerd in: (2007)